Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Director's Dealing 2010

Nov 10, 2010

29777_dirs_2010-11-10_48d432ca-25b7-452f-9bc3-efca900a3fad.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2010-11-09

Reporting Person: Warmuth Michael J (Senior Vice President)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-11-09 Common shares without par value M 11172 $45.4488 Acquired 116362 Direct
2010-11-09 Common shares without par value S 4372 $50.10 Disposed 111990 Direct
2010-11-09 Common shares without par value S 200 $50.1007 Disposed 111790 Direct
2010-11-09 Common shares without par value S 200 $50.1015 Disposed 111590 Direct
2010-11-09 Common shares without par value S 6300 $50.101 Disposed 105290 Direct
2010-11-09 Common shares without par value S 100 $50.1003 Disposed 105190 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-11-09 Option (right to buy) $45.4488 M 11172 Disposed 2011-02-08 Common shares (11172) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common shares without par value 72 Indirect

Footnotes

F1: The reporting person disclaims beneficial ownership of all securities held by his spouse.

F2: Employee stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exempt from Section 16 under Rule 16b-3.